R.H. Dinel Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7M Hold
19,325
5.37% 6
2026
Q1
$6.8M Hold
19,325
5.5% 4
2025
Q4
$6.33M Sell
19,325
-3,200
-14% -$1.02M 4.64% 8
2025
Q3
$6.36M Hold
22,525
4.1% 8
2025
Q2
$6.29M Sell
22,525
-525
-2% -$149K 4.19% 8
2025
Q1
$7.18M Hold
23,050
4.9% 7
2024
Q4
$6.01M Hold
23,050
4.01% 8
2024
Q3
$7.43M Hold
23,050
4.64% 8
2024
Q2
$7.2M Buy
23,050
+1,350
+6% +$397K 4.61% 6
2024
Q1
$6.17M Hold
21,700
3.95% 9
2023
Q4
$6.25M Buy
21,700
+1,250
+6% +$341K 4.27% 8
2023
Q3
$5.5M Hold
20,450
3.96% 9
2023
Q2
$4.54M Hold
20,450
3.18% 11
2023
Q1
$4.94M Hold
20,450
3.72% 9
2022
Q4
$5.37M Hold
20,450
4.81% 7
2022
Q3
$4.61M Hold
20,450
4.59% 7
2022
Q2
$4.97M Hold
20,450
4.48% 7
2022
Q1
$4.95M Hold
20,450
3.8% 8
2021
Q4
$4.6M Hold
20,450
3.17% 9
2021
Q3
$4.35M Hold
20,450
3.26% 10
2021
Q2
$4.99M Hold
20,450
3.55% 9
2021
Q1
$5.09M Hold
20,450
3.89% 8
2020
Q4
$4.7M Hold
20,450
3.78% 8
2020
Q3
$5M Hold
20,450
4.77% 7
2020
Q2
$4.82M Hold
20,450
4.69% 6
2020
Q1
$4.15M Hold
20,450
4.9% 5
2019
Q4
$4.93M Hold
20,450
4.36% 7
2019
Q3
$3.96M Hold
20,450
3.68% 10
2019
Q2
$3.77M Hold
20,450
3.49% 10
2019
Q1
$3.88M Hold
20,450
3.84% 8
2018
Q4
$3.98M Buy
+20,450
New +$3.99M 4.47% 7
2016
Q3
$3.74M Buy
22,400
+375
+2% +$63.4K 4.18% 5
2016
Q2
$3.35M Hold
22,025
3.93% 6
2016
Q1
$3.3M Hold
22,025
3.88% 5
2015
Q4
$3.58M Hold
22,025
4.05% 7
2015
Q3
$3.05M Hold
22,025
3.18% 8
2015
Q2
$3.38M Buy
22,025
+650
+3% +$104K 3.17% 11
2015
Q1
$3.42M Buy
21,375
+3,425
+19% +$539K 3.21% 8
2014
Q4
$2.86M Hold
17,950
2.55% 13
2014
Q3
$2.52M Buy
17,950
+4,200
+31% +$548K 2.28% 15
2014
Q2
$1.63M Sell
13,750
-575
-4% -$66.6K 1.48% 29
2014
Q1
$1.77M Hold
14,325
1.56% 25
2013
Q4
$1.63M Buy
+14,325
New +$1.63M 1.44% 30

Other funds holding AMGN

R.H. Dinel Investment Counsel's AMGN Position: Q2 2026 in Review

R.H. Dinel Investment Counsel held its Amgen (AMGN) position steady in Q2 2026 at 19,325 shares worth $7M. The position accounts for 5.37% of the portfolio, ranked #6.

R.H. Dinel Investment Counsel first reported a position in AMGN in Q4 2013 and has held it in 43 quarters since. The position peaked at $7.43M in Q3 2024. 1,909 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • R.H. Dinel Investment Counsel held 19,325 shares of Amgen worth $7M as of Q2 2026.
  • R.H. Dinel Investment Counsel left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 5.37% of R.H. Dinel Investment Counsel's portfolio in Q2 2026, its #6 holding.
  • R.H. Dinel Investment Counsel first reported a position in Amgen in Q4 2013 and has held it in 43 quarters since.
  • R.H. Dinel Investment Counsel's Amgen position peaked at $7.43M in Q3 2024.
  • 1,909 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on R.H. Dinel Investment Counsel's 13F filing for Q2 2026, filed 13 Jul 2026.